Trypsin is a proteolytic enzyme that aids in digestion. Inactive trysinogen formed by the pancreas gets converted into active trypsin in the small intestine. Trypsinogen, along with other proetinases like pepsin and chymotrypsin, breaks down protein from food into amino acids. Amino acids carry out various functions such as repairing tissues, producing hormones, potentiating muscle growth, and others. When enough trypsin is not produced by the body, it leads to a condition called malabsorption. Moreover, malabsorption may also occur due to a number of conditions such as cystic fibrosis, pancreatitis, and others. Trypsin is given to patients who lack the digestive enzymes required.
The increasing adoption of inorganic strategies such as collaborations and agreements by the key players is expected to drive the global trypsin market over the forecast period. For instance, in September 2021, Thermo Fisher Scientific, a U.S.-based supplier of scientific instrumentation, reagents and consumables, and software services, and AstraZeneca, a multinational pharmaceutical and biotechnology company, announced to collaborate to develop next-generation sequencing (NGS)-based companion diagnostics (CDx). This collaboration was to support AstraZeneca's growing portfolio of targeted therapies. The companies will work together on a multiyear, global agreement.
- This report provides an in-depth analysis of the global trypsin market, and provides market size (USD Mn), and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global trypsin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Promega Corporation, Merck KgaA, Geno Technology Inc., USA., Thermo Fisher Scientific Inc., SignalChem Biotech Inc., Takara Bio Inc., Creative Enzymes, ProteoChem, Waters Corporation, Bioseutica, Bovogen Biologicals Pty Ltd., and BBI Solutions
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global trypsin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global trypsin market
-
-
-
- Protein Identification
- Quantitative Analysis
- Differential Expression
- Post-translational Modifications
-
- Academic & Research Institutes
- Pharmaceutical Companies
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
-
- Promega Corporation
- Merck KgaA
- Geno Technology Inc., USA.
- Thermo Fisher Scientific Inc.
- SignalChem Biotech Inc.
- Takara Bio Inc.
- Creative Enzymes
- ProteoChem
- Waters Corporation
- Bioseutica
- Bovogen Biologicals Pty Ltd.
- BBI Solutions
